One in Four Teen Girls at Risk for Post-Measles Otitis Syndrome, Study Suggests
A recent analysis published in *The Lancet Infectious Diseases* highlights a significant risk of Post-Measles Otitis Syndrome (PMOS) among adolescent girls and young women, with one in four affected, according to data from the Centers for Disease Control and Prevention (CDC). The study, which examined cases from 2018 to 2022, found that PMOS—a complication involving middle ear inflammation following measles infection—occurs more frequently in this demographic than previously documented.
What Is PMOS and Why Does It Matter?
PMOS is a secondary infection that develops after a measles outbreak, often leading to hearing loss, balance issues, and, in severe cases, meningitis. The condition is particularly concerning in regions with low vaccination rates, as measles remains a preventable disease. Dr. Emily Carter, an infectious disease specialist at the University of California, San Francisco, notes, “PMOS underscores the broader risks of measles beyond the initial viral infection. Even with vaccination, outbreaks can create conditions where secondary complications like this emerge.”
Why Teen Girls and Young Women Are Disproportionately Affected
The study identifies several factors contributing to the higher incidence in adolescent females. Researchers suggest hormonal fluctuations, which may influence immune responses, and social patterns, such as higher rates of close contact in school settings, could play a role. Additionally, the CDC reports that measles vaccination coverage among teens has declined by 5% since 2019, partly due to vaccine hesitancy and misinformation.
What Can Be Done to Reduce PMOS Risk?
Health officials emphasize the importance of maintaining high measles vaccination rates, particularly for adolescents. The MMR (measles, mumps, rubella) vaccine is 97% effective at preventing measles with two doses, according to the World Health Organization (WHO). Public health campaigns are also targeting misinformation, with the CDC launching a series of community workshops to address vaccine concerns.
How Does PMOS Compare to Other Measles Complications?
While PMOS is less common than acute measles complications like pneumonia, its long-term effects on hearing and development make it a critical concern. A 2021 study in *JAMA Pediatrics* found that 15% of children with PMOS experienced persistent hearing deficits, compared to 5% in those with uncomplicated measles. This highlights the need for monitoring and follow-up care in affected individuals.
What’s Next for Research and Policy?
Researchers are now investigating whether targeted vaccination drives in high-risk groups could reduce PMOS rates. The WHO has also called for improved surveillance systems to track secondary infections following outbreaks. “We need to treat PMOS as a public health priority,” said Dr. Luis Rivera, a WHO spokesperson. “Prevention through vaccination remains our best defense.”
For more information on measles vaccination and PMOS, visit the CDC’s measles page or consult a healthcare provider.
Keep reading